FDA authorizes Regeneron's Covid treatment, taken by Trump, for emergency use

Nov 22, 2020 , CNBC Health
Regeneron's therapy is part of a class of treatments known as monoclonal antibodies, which are made to act as immune cells that scientists hope can fight infections.

Read the full story...

Trending healthcare news keywords at this moment

covid- pandemic coronavirus vaccine covid people fda study